{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T14:09:33Z","timestamp":1788876573465,"version":"build-2803163510"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,27]],"date-time":"2023-07-27T00:00:00Z","timestamp":1690416000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Regenerative Therapy"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.reth.2023.07.007","type":"journal-article","created":{"date-parts":[[2023,8,2]],"date-time":"2023-08-02T12:46:04Z","timestamp":1690980364000},"page":"282-287","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Characterization of dynamical changes in vital signs during allogeneic human umbilical cord-derived mesenchymal stem cells infusion"],"prefix":"10.1016","volume":"24","author":[{"given":"Yue","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiping","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongming","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiqi","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changqin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peichen","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinfang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8645-1114","authenticated-orcid":false,"given":"Congrong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongmin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.reth.2023.07.007_bib1","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/s41581-018-0023-5","article-title":"Immunoregulatory mechanisms of mesenchymal stem and stromal cells in inflammatory diseases","volume":"14","author":"Shi","year":"2018","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.reth.2023.07.007_bib3","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.2337\/dc14-2830","article-title":"Allogeneic mesenchymal precursor cells in type 2 diabetes: a randomized, placebo-controlled, dose-escalation safety and tolerability pilot study","volume":"38","author":"Skyler","year":"2015","journal-title":"Diabetes Care"},{"key":"10.1016\/j.reth.2023.07.007_bib4","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1002\/sctm.18-0122","article-title":"Intra-articular injection of autologous adipose tissue-derived mesenchymal stem cells for the treatment of knee osteoarthritis: a phase IIb, randomized, placebo-controlled clinical trial","volume":"8","author":"Lee","year":"2019","journal-title":"Stem Cells Translational Medicine"},{"key":"10.1016\/j.reth.2023.07.007_bib5","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1007\/s11684-011-0116-z","article-title":"Transplantation of placenta-derived mesenchymal stem cells in type 2 diabetes: a pilot study","volume":"5","author":"Jiang","year":"2011","journal-title":"Front Med"},{"key":"10.1016\/j.reth.2023.07.007_bib6","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1002\/sctm.18-0031","article-title":"Intravenous infusion of umbilical cord blood-derived mesenchymal stem cells in rheumatoid arthritis: a phase ia clinical trial","volume":"7","author":"Park","year":"2018","journal-title":"Stem Cells Translational Medicine"},{"key":"10.1016\/j.reth.2023.07.007_bib8","article-title":"Cell therapy with intravascular administration of mesenchymal stromal cells continues to appear safe: an updated systematic review and meta-analysis","volume":"19","author":"Thompson","year":"2020","journal-title":"EClinical Medicine"},{"key":"10.1016\/j.reth.2023.07.007_bib9","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1002\/sctm.19-0010","article-title":"Allogeneic human umbilical cord mesenchymal stem cells for the treatment of autism spectrum disorder in children: safety profile and effect on cytokine levels","volume":"8","author":"Riordan","year":"2019","journal-title":"Stem Cells Translational Medicine"},{"key":"10.1016\/j.reth.2023.07.007_bib10","doi-asserted-by":"crossref","first-page":"73","DOI":"10.5009\/gnl17035","article-title":"Umbilical cord mesenchymal stem cell treatment for Crohn's disease: a randomized controlled clinical trial","volume":"12","author":"Zhang","year":"2018","journal-title":"Gut Liver"},{"key":"10.1016\/j.reth.2023.07.007_bib11","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1186\/s13287-020-01875-5","article-title":"Treatment of severe COVID-19 with human umbilical cord mesenchymal stem cells","volume":"11","author":"Shu","year":"2020","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.reth.2023.07.007_bib12","doi-asserted-by":"crossref","first-page":"967","DOI":"10.3389\/fneur.2020.00967","article-title":"IV\/IT hUC-MSCs infusion in rrms and nmo: a 10-year follow-up study","volume":"11","author":"Lu","year":"2020","journal-title":"Front Neurol"},{"key":"10.1016\/j.reth.2023.07.007_bib13","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.3892\/etm.2017.4229","article-title":"Intravenous infusion umbilical cord-derived mesenchymal stem cell in primary immune thrombocytopenia: a two-year follow-up","volume":"13","author":"Wang","year":"2017","journal-title":"Exp Ther Med"},{"key":"10.1016\/j.reth.2023.07.007_bib14","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.intimp.2018.04.051","article-title":"The homing of human umbilical cord-derived mesenchymal stem cells and the subsequent modulation of macrophage polarization in type 2 diabetic mice","volume":"60","author":"Yin","year":"2018","journal-title":"Int Immunopharm"},{"key":"10.1016\/j.reth.2023.07.007_bib15","doi-asserted-by":"crossref","first-page":"8407","DOI":"10.1073\/pnas.1432929100","article-title":"Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects","volume":"100","author":"Ortiz","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.reth.2023.07.007_bib16","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1161\/01.CIR.0000084828.50310.6A","article-title":"Systemic delivery of bone marrow-derived mesenchymal stem cells to the infarcted myocardium: feasibility, cell migration, and body distribution","volume":"108","author":"Barbash","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.reth.2023.07.007_bib17","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1161\/CIRCULATIONAHA.105.537480","article-title":"Dynamic imaging of allogeneic mesenchymal stem cells trafficking to myocardial infarction","volume":"112","author":"Kraitchman","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.reth.2023.07.007_bib18","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.jcyt.2017.09.013","article-title":"Intramuscular administration potentiates extended dwell time of mesenchymal stromal cells compared to other routes","volume":"20","author":"Braid","year":"2018","journal-title":"Cytotherapy"},{"key":"10.1016\/j.reth.2023.07.007_bib19","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.molmed.2018.12.006","article-title":"Intravascular mesenchymal stromal\/stem cell therapy product diversification: time for new clinical guidelines","volume":"25","author":"Moll","year":"2019","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.reth.2023.07.007_bib20","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1161\/01.HYP.0000107251.49515.c2","article-title":"Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of High blood pressure","volume":"42","author":"Chobanian","year":"2003","journal-title":"Hypertension"},{"key":"10.1016\/j.reth.2023.07.007_bib21","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1161\/01.STR.0000126208.14181.DD","article-title":"Blood pressure and stroke: an overview of published reviews","volume":"35","author":"Lawes","year":"2004","journal-title":"Stroke"},{"key":"10.1016\/j.reth.2023.07.007_bib22","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1161\/01.HYP.0000165020.14745.79","article-title":"Systolic and diastolic blood pressure lowering as determinants of cardiovascular outcome","volume":"45","author":"Wang","year":"2005","journal-title":"Hypertension"},{"key":"10.1016\/j.reth.2023.07.007_bib23","article-title":"Priming mesenchymal stem cells with endothelial growth medium boosts stem cell therapy for systemic arterial hypertension","volume":"2015","author":"de Oliveira","year":"2015","journal-title":"Stem Cell Int"},{"key":"10.1016\/j.reth.2023.07.007_bib24","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.pharmthera.2014.02.013","article-title":"Mesenchymal stem\/stromal cells as a pharmacological and therapeutic approach to accelerate angiogenesis","volume":"143","author":"Bronckaers","year":"2014","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.reth.2023.07.007_bib25","doi-asserted-by":"crossref","first-page":"H2865","DOI":"10.1152\/ajpheart.2000.279.6.H2865","article-title":"Hepatocyte growth factor is upregulated by low-density lipoproteins and inhibits endothelin-1 release","volume":"279","author":"Haug","year":"2000","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.reth.2023.07.007_bib26","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1203\/00006450-200212000-00016","article-title":"Vascular endothelial growth factor causes pulmonary vasodilation through activation of the phosphatidylinositol-3-kinase-nitric oxide pathway in the late-gestation ovine fetus","volume":"52","author":"Grover","year":"2002","journal-title":"Pediatr Res"},{"key":"10.1016\/j.reth.2023.07.007_bib27","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1016\/j.jpedsurg.2019.02.037","article-title":"Inhibiting hydrogen sulfide production in umbilical stem cells reduces their protective effects during experimental necrotizing enterocolitis","volume":"54","author":"Drucker","year":"2019","journal-title":"J\u00a0Pediatr Surg"},{"key":"10.1016\/j.reth.2023.07.007_bib28","doi-asserted-by":"crossref","first-page":"G441","DOI":"10.1152\/ajpgi.00132.2019","article-title":"Mesenchymal stem cells promote mesenteric vasodilation through hydrogen sulfide and endothelial nitric oxide","volume":"317","author":"Te Winkel","year":"2019","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.reth.2023.07.007_bib29","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1016\/j.ymthe.2018.05.009","article-title":"Mesenchymal stem cell-based therapy for cardiovascular disease: progress and challenges","volume":"26","author":"Bagno","year":"2018","journal-title":"Mol Ther"},{"key":"10.1016\/j.reth.2023.07.007_bib30","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.ebiom.2015.03.020","article-title":"Allogeneic mesenchymal stem cells restore endothelial function in heart failure by stimulating endothelial progenitor cells","volume":"2","author":"Premer","year":"2015","journal-title":"EBioMedicine"},{"key":"10.1016\/j.reth.2023.07.007_bib31","doi-asserted-by":"crossref","first-page":"44","DOI":"10.5966\/sctm.2014-0091","article-title":"Mesenchymal stem cells ameliorate atherosclerotic lesions via restoring endothelial function","volume":"4","author":"Lin","year":"2015","journal-title":"Stem CellsTransl Med"},{"key":"10.1016\/j.reth.2023.07.007_bib32","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.742088","article-title":"Mesenchymal stem cell immunomodulation: a novel intervention mechanism in cardiovascular disease","volume":"9","author":"Wang","year":"2022","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.reth.2023.07.007_bib33","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/j.1748-1716.2009.01964.x","article-title":"Endothelial dysfunction and vascular disease","volume":"196","author":"Vanhoutte","year":"2009","journal-title":"Acta Physiol"},{"key":"10.1016\/j.reth.2023.07.007_bib34","first-page":"368","article-title":"Oxygen saturation in postoperative patients at low risk for hypoxemia: is oxygen therapy needed?","volume":"80","author":"Gift","year":"1995","journal-title":"Anesth Analg"},{"key":"10.1016\/j.reth.2023.07.007_bib35","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1038\/sj.bmt.1705100","article-title":"Variation in dimethylsulfoxide use in stem cell transplantation: a survey of EBMT centres","volume":"36","author":"Windrum","year":"2005","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.reth.2023.07.007_bib36","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.ymthe.2004.02.012","article-title":"Internalized antigens must be removed to prepare hypoimmunogenic mesenchymal stem cells for cell and gene therapy","volume":"9","author":"Spees","year":"2004","journal-title":"Mol Ther"}],"container-title":["Regenerative Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352320423000731?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352320423000731?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T17:40:07Z","timestamp":1762450807000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352320423000731"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":34,"alternative-id":["S2352320423000731"],"URL":"https:\/\/doi.org\/10.1016\/j.reth.2023.07.007","relation":{},"ISSN":["2352-3204"],"issn-type":[{"value":"2352-3204","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characterization of dynamical changes in vital signs during allogeneic human umbilical cord-derived mesenchymal stem cells infusion","name":"articletitle","label":"Article Title"},{"value":"Regenerative Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.reth.2023.07.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Japanese Society for Regenerative Medicine. Production and hosting by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}